Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:17 pm Unchanged | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 64,178,259 85.200% | 0 (Unchanged) | View |
| 2024-05-13 1:58 pm Unchanged | 13G | Innoviva Inc. INVA | FRANKLIN RESOURCES INC BEN | 6,412,700 10.200% | 0 (Unchanged) | View |
| 2024-05-08 3:38 pm Purchase | 13D | Innoviva Inc. INVA | FRANKLIN RESOURCES INC BEN | 6,412,700 10.200% | 6,412,700 (New Position) | View |
| 2024-03-04 5:35 pm Unchanged | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 64,178,259 85.300% | 0 (Unchanged) | View |
| 2024-02-14 07:23 am Purchase | 13G | Innoviva Inc. INVA | PUTNAM INVESTMENTS LLC | 6,270,413 9.800% | 941,306 (+17.66%) | View |
| 2024-02-13 5:06 pm Sale | 13G | Innoviva Inc. INVA | VANGUARD GROUP INC | 6,712,443 10.470% | -359,769 (-5.09%) | View |
| 2024-02-13 10:26 am Sale | 13G | Innoviva Inc. INVA | RENAISSANCE TECHNOLOGIES LLC | 4,144,447 6.470% | -85,160 (-2.01%) | View |
| 2024-02-09 09:59 am Purchase | 13G | Innoviva Inc. INVA | DIMENSIONAL FUND ADVISORS LP | 4,516,999 7.000% | 4,516,999 (New Position) | View |
| 2024-01-22 2:03 pm Sale | 13G | Innoviva Inc. INVA | BlackRock Inc. BLK | 10,349,116 16.100% | -262,723 (-2.48%) | View |
| 2023-07-11 08:27 am Unchanged | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 64,178,259 85.300% | 0 (Unchanged) | View |
| 2023-05-15 5:05 pm Purchase | 13D | Innoviva Inc. INVA | Sarissa Capital Management LP | 6,904,000 10.540% | 490,000 (+7.64%) | View |
| 2023-02-14 1:05 pm Purchase | 13G | Innoviva Inc. INVA | PUTNAM INVESTMENTS LLC | 5,329,107 7.600% | 5,329,107 (New Position) | View |
| 2023-02-13 10:27 am Sale | 13G | Innoviva Inc. INVA | RENAISSANCE TECHNOLOGIES LLC | 4,229,607 6.060% | -1,065,526 (-20.12%) | View |
| 2023-02-10 2:11 pm Unchanged | 13G | Innoviva Inc. INVA | BlackRock Inc. BLK | 10,611,839 15.200% | 0 (Unchanged) | View |
| 2023-02-09 11:22 am Purchase | 13G | Innoviva Inc. INVA | VANGUARD GROUP INC | 7,072,212 10.130% | 101,262 (+1.45%) | View |
| 2023-02-01 7:39 pm Purchase | 13G | Innoviva Inc. INVA | WESTFIELD CAPITAL MANAGEMENT CO LP | 4,106,136 5.880% | 422,651 (+11.47%) | View |
| 2023-01-26 08:52 am Purchase | 13G | Innoviva Inc. INVA | BlackRock Inc. BLK | 10,611,839 10.600% | 4,940,739 (+87.12%) | View |
| 2023-01-20 5:17 pm Sale | 13G | Innoviva Inc. INVA | BlackRock Inc. BLK | 5,671,100 10.600% | -3,337,658 (-37.05%) | View |
| 2023-01-10 5:12 pm Purchase | 13D | ARMATA PHARMACEUTICALS INC ARMP | Innoviva Inc. INVA | 64,178,259 85.300% | 19,736,843 (+44.41%) | View |
| 2022-07-11 5:27 pm Sale | 13D | Entasis Therapeutics Holdings Inc. ETTX | Innoviva Inc. INVA | 100 100.000% | -57,345,694 (-100.00%) | View |